Cardiac Biomarkers: Expert Advice for Clinicians

2007 ◽  
Author(s):  
Judith A. Stanley ◽  
R. Scott Chavez

2020 ◽  
Vol 3 (1) ◽  
pp. 7-17
Author(s):  
Ana Clara Sarzedas Ribeiro ◽  
◽  
Gliére Silmara Leite Soares ◽  
Saulo de Tarso Gusmão da Silva ◽  
Eldinê Gomes de Miranda Neto ◽  
...  

2020 ◽  
Vol 3 (1) ◽  
pp. 7-16
Author(s):  
Ana Clara Sarzedas Ribeiro ◽  
Gliére Silmara Leite Soares ◽  
Saulo de Tarso Gusmão da Silva ◽  
Eldinê Gomes de Miranda Neto ◽  
Rebeka Menezes Pontes ◽  
...  

Author(s):  
Shivananda B Nayak ◽  
Dharindra Sawh ◽  
Brandon Scott ◽  
Vestra Sears ◽  
Kareshma Seebalack ◽  
...  

Purpose: i) To determine the relationship between the cardiac biomarkers ST2 and NT-proBNP with ejection fraction (EF) in heart failure (HF) patients. ii) Assess whether a superiority existed between the aforementioned cardiac markers in diagnosing the HF with reduced EF. iii) Determine the efficacy of both biomarkers in predicting a 30-day cardiovascular event and rehospitalization in patients with HF with reduced EF iv) To assess the influence of age, gender, BMI, anaemia and renal failure on the ST2 and NT-proBNP levels. Design and Methods: A prospective double-blind study was conducted to obtain data from a sample of 64 cardiology patients. A blood sample was collected to test for ST2 and NT-proBNP. An echocardiogram (to obtain EF value), electrocardiogram and questionnaire were also obtained. Results: Of the 64 patients enrolled, 59.4% of the population had an EF less than 40%. At the end of the 30- day period, 7 patients were warded, 37 were not warded, one died and 17 were non respondent. Both biomarkers were efficacious at diagnosing HF with a reduced EF. However, neither of them were efficacious in predicting 30-day rehospitalization. The mean NT-proBNP values being: not rehospitalized (2114.7486) and 30 day rehospitalization (1008.42860) and the mean ST2 values being: not rehospitalized (336.1975), and 30-day rehospitalization. (281.9657). Conclusion: Neither ST2 or NT-proBNP was efficacious in predicting the short- term prognosis in HF with reduced EF. Both however were successful at confirming the diagnosis of HF in HF patients with reduced EF.


HortScience ◽  
1996 ◽  
Vol 31 (4) ◽  
pp. 650f-650
Author(s):  
Mark P. Widrlechner

In 1991, the USDA–ARS North Central Regional Plant Introduction Station made available for distribution 129 accessions of germplasm representing 31 genera of herbaceous ornamentals. This number increased to 329 accessions of 42 genera by 1995. During 1991–95, more than 500 seed packets were distributed to fulfill requests for these plants received from a diverse array of public and private researchers. An analysis of this demand together with expert advice from Crop Germplasm Committees and technical considerations, such as ease of culture and seed production, can help set priorities to plan germplasm regeneration to meet future demand. A recent analysis of demand at U.S. National Plant Germplasm System active sites indicated that demand ranging between 0.23 and 0.97 distributions per available accession per year was typical. Of the 42 ornamental genera analyzed in this study, 9 were demanded more frequently than was typical, 10 were demanded less frequently, with the remainder in the typical range. In order of increasing frequency, the nine genera with the highest distribution rates were Verbena, Gypsophila, Echinacea, Lapeirousia, Delphinium, Cerastium, Baptisia, Lilium, and Tanacetum. Six of these genera are represented only by a single available accession. Notably, Echinacea and Tanacetum are of research interest both as ornamentals and as medicinal/industrial crops. This poster gives a brief overview of the economic value of these genera, display the results of the demand analysis, discuss the results relative to recommendations from Crop Germplasm Committees and requestors, and consider how demand can shape management plans for the acquisition and regeneration of ornamental germplasm.


Sign in / Sign up

Export Citation Format

Share Document